These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3713738)

  • 1. A mathematical analysis of creatine kinase activity in the course of Duchenne muscular dystrophy.
    Pernice W; Guggolz MA; Guggolz M; Beckmann R; Wais U
    Muscle Nerve; 1986 May; 9(4):333-40. PubMed ID: 3713738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differential diagnosis of Becker and Duchenne muscular dystrophy].
    Alvarez Leal M; Hernández Sifuentes PM; Pérez-Zuno JA
    Gac Med Mex; 1994; 130(6):454-8. PubMed ID: 7557060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatine kinase activity in normal and Duchenne muscular dystrophy fibroblasts.
    Davis MH; Cappel R; Vester JW; Samaha FJ; Gruenstein E
    Muscle Nerve; 1982 Jan; 5(1):1-6. PubMed ID: 7057800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the creatine kinase MM isoforms of normal and Duchenne muscular dystrophic patients.
    Zhao X; Bi C; Yang Z
    Chin Med J (Engl); 1998 Jan; 111(1):75-7. PubMed ID: 10322660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods.
    Mokuno K; Riku S; Sugimura K; Takahashi A; Kato K; Osugi S
    Muscle Nerve; 1987 Jun; 10(5):459-63. PubMed ID: 3302699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy.
    Ionasescu V; Ionasescu R; Feld R; Witte D; Cancilla P; Kaeding L; Stern LZ
    Ann Neurol; 1981 Apr; 9(4):394-9. PubMed ID: 7224603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum myoglobin in muscular dystrophy.
    Kagen LJ; Moussavi S; Miller SL; Tsairis P
    Muscle Nerve; 1980; 3(3):221-6. PubMed ID: 7374673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relations between delayed diagnosis and forms of onset in Duchenne muscular dystrophy].
    Alvarez Leal M; Morales Aguilera A; Pérez Zuno JA; Segura Romero S; Quiroz Góngora MC; Paredes García A
    Gac Med Mex; 1994; 130(6):459-64. PubMed ID: 7557061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
    Pernice W; Beckmann R; Renner S; Wais U
    Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on genetic heterogeneity in Duchenne muscular dystrophy.
    Rabbi-Bortolini E; Zatz M
    Am J Med Genet; 1986 May; 24(1):111-7. PubMed ID: 3706399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibility of prenatal diagnosis of progressive muscular dystrophy: evaluation of creatine kinase activity in serum and the capping of lymphocytes].
    Venturoli A; Sensi A; Baricordi R; Artioli A; Osti L; Mari R; Ferroni G; Lucci M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1988-94. PubMed ID: 6608363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening.
    Hauser E; Toifl K; Mad A; Bittner R
    Wien Klin Wochenschr; 1993; 105(15):433-6. PubMed ID: 8104369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinase and its application in an infant screening program.
    Scheuerbrandt G; Lundin A; Lövgren T; Mortier W
    Muscle Nerve; 1986 Jan; 9(1):11-23. PubMed ID: 3951477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum CK-MB activity in progressive muscular dystrophy: is it of nosologic value?
    Vainzof M; Zatz M; Otto PA
    Am J Med Genet; 1985 Sep; 22(1):81-7. PubMed ID: 4050853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR; Gonzalez CH; Zatz M
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum creatine kinase BB and MM concentrations determined by radioimmunoassay in neuromuscular disorders.
    Zweig MH; Adornato B; Van Steirteghem AC; Engel WK
    Ann Neurol; 1980 Apr; 7(4):324-8. PubMed ID: 7377757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma creatine kinase and myoglobin levels, before and after abortion, in human fetuses at risk for Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Am J Med Genet; 1983 Jul; 15(3):475-82. PubMed ID: 6881213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neonatal screening for duchenne myopathy by serum elevation of creatine phosphokinase activity. 5 years experience].
    Plauchu H; Dellamonica C; Pascal B; Jolivet MJ; Guibaud P; Cotte J; Robert JM
    J Genet Hum; 1981 Mar; 29(1):59-69. PubMed ID: 7334342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy.
    Zatz M; Rapaport D; Vainzof M; Passos-Bueno MR; Bortolini ER; Pavanello Rde C; Peres CA
    J Neurol Sci; 1991 Apr; 102(2):190-6. PubMed ID: 2072118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.